From: The apolipoprotein receptor LRP3 compromises APP levels
 | Age (y) | Gender | PM (h) | SP | ApoE |
---|---|---|---|---|---|
MA NFT | |||||
 0 | 46 | f | 9.5 | 0 | ɛ2/ɛ3 |
46 | m | 15 | ɛ3/ɛ4 | ||
47 | m | 5 | ɛ3/ɛ3 | ||
49 | m | 7.5 | ɛ3/ɛ3 | ||
50 | m | 17 | ɛ3/ɛ3 | ||
52 | m | 5 | ɛ3/ɛ3 | ||
52 | f | 6 | ɛ4/ɛ4 | ||
53 | m | 7.5 | ɛ3/ɛ3 | ||
56 | m | 4 | ɛ2/ɛ3 | ||
59 | m | 6,5 | ɛ3/ɛ3 | ||
60 | f | 11.5 | ɛ3/ɛ3 | ||
AD NFT | |||||
 Braak I | 53 | m | 6.25 | A | ɛ3/ɛ4 |
64 | m | 8.5 | 0 | ɛ3/ɛ3 | |
67 | m | 14.5 | 0 | ɛ3/ɛ3 | |
68 | m | 11 | 0 | ɛ2/ɛ3 | |
 Braak II | 57 | m | 4.5 | 0 | ɛ3/ɛ4 |
60 | f | 9.5 | A | ɛ3/ɛ3 | |
65 | m | 16.5 | 0 | ɛ3/ɛ3 | |
67 | m | 7.25 | 0 | ɛ3/ɛ4 | |
69 | m | 3.5 | A | ɛ3/ɛ4 | |
72 | m | 6.25 | A | ɛ3/ɛ4 | |
74 | m | 5.5 | A | ɛ2/ɛ3 | |
78 | m | 16 | 0 | ɛ3/ɛ3 | |
78 | m | 10.75 | B | ɛ3/ɛ4 | |
86 | m | 5.5 | A | ɛ2/ɛ3 | |
 Braak III | 68 | f | 4.5 | A | ɛ3/ɛ3 |
71 | m | 7.5 | 0 | ɛ2/ɛ3 | |
73 | m | 4 | 0 | ɛ3/ɛ3 | |
76 | f | 4 | B | ɛ3/ɛ3 | |
77 | m | 13.5 | C | ɛ3/ɛ4 | |
77 | m | 5.5 | A | ɛ3/ɛ3 | |
79 | f | 3.5 | B | ɛ3/ɛ3 | |
82 | f | 5 | A | ɛ3/ɛ3 | |
90 | f | 4 | B | ɛ3/ɛ3 | |
 Braak IV | 79 | m | 5 | A | ɛ4/ɛ4 |
81 | f | 5 | C | ɛ3/ɛ3 | |
85 | m | 14 | B | ɛ3/ɛ4 | |
89 | m | 3.5 | B | ɛ3/ɛ4 | |
99 | f | 5 | B | ɛ3/ɛ3 | |
 Braak V | 72 | m | 2.75 | C | ɛ3/ɛ4 |
73 | m | 4.5 | B | ɛ3/ɛ4 | |
74 | f | 9 | A | ɛ3/ɛ4 | |
75 | m | 11.5 | B | ɛ3/ɛ4 | |
77 | m | 16 | C | ɛ3/ɛ3 | |
78 | m | 17 | 0 | ɛ3/ɛ3 | |
81 | f | 5.5 | C | ɛ3/ɛ4 | |
87 | m | 7 | C | ɛ3/ɛ3 | |
93 | m | 3 | C | ɛ3/ɛ3 | |
 Braak VI | 56 | f | 7 | C | ɛ3/ɛ3 |
67 | f | 8 | C | ɛ3/ɛ4 | |
86 | f | 20.5 | C | ɛ3/ɛ3 |